tradingkey.logo

Cigna Group

CI

311.760USD

+1.929+0.62%
交易中 03/06, 11:08美东报价延迟15分钟
85.35B总市值
24.86市盈率 TTM

Cigna Group

311.760

+1.929+0.62%
关于 Cigna Group 公司
公司简介
公司代码CI
公司名称Cigna Group
上市日期Apr 01, 1982
成立日期2018
CEOMr. Eric P. Palmer
员工数量73500
证券类型Ordinary Share
年结日Apr 01
公司地址- -
城市- -
上市交易所NYSE Consolidated
国家- -
邮编- -
电话- -
网址- -
公司代码CI
上市日期Apr 01, 1982
成立日期2018
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
653.62K
-3.90%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare
Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare
60.38K
+20.44%
Ms. Noelle K. Eder
Ms. Noelle K. Eder
Executive Vice President, Global Chief Information Officer
Executive Vice President, Global Chief Information Officer
29.75K
+28.79%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.09K
+2.11%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
22.52K
+2.45%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President and Chief Health Officer
Executive Vice President and Chief Health Officer
9.04K
-3.11%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
5.47K
+10.93%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
5.47K
--
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
5.47K
+10.93%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
3.87K
+16.16%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
653.62K
-3.90%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare
Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna Healthcare
60.38K
+20.44%
Ms. Noelle K. Eder
Ms. Noelle K. Eder
Executive Vice President, Global Chief Information Officer
Executive Vice President, Global Chief Information Officer
29.75K
+28.79%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.09K
+2.11%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
22.52K
+2.45%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President and Chief Health Officer
Executive Vice President and Chief Health Officer
9.04K
-3.11%
收入明细
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
业务USD
名称
营收
占比
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.47B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.05B
0.00%
暂无数据
业务
地区
业务USD
名称
营收
占比
Pharmacy revenues
185.36B
0.00%
Network revenues
105.34B
0.00%
Home delivery and specialty revenues
72.47B
0.00%
Fees and other revenues
14.79B
0.00%
Other revenues
11.54B
0.00%
Intercompany eliminations
-4.05B
0.00%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
4.89%
State Street Global Advisors (US)
4.64%
MFS Investment Management
4.10%
T. Rowe Price Associates, Inc.
3.86%
Other
73.00%
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
4.89%
State Street Global Advisors (US)
4.64%
MFS Investment Management
4.10%
T. Rowe Price Associates, Inc.
3.86%
Other
73.00%
股东类型
股东统计
占比
Investment Advisor
41.63%
Investment Advisor/Hedge Fund
39.78%
Pension Fund
2.42%
Research Firm
2.24%
Hedge Fund
1.99%
Bank and Trust
1.66%
Sovereign Wealth Fund
1.26%
Corporation
1.25%
Holding Company
0.43%
Other
7.30%
机构持股
更新时间: 1月19日 周日
更新时间: 1月19日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q1
2874
255.12M
93.18%
-3.90M
2024Q4
2993
255.45M
93.32%
-4.13M
2024Q3
2931
253.73M
90.72%
-10.03M
2024Q2
2910
254.99M
91.23%
-15.88M
2024Q1
2865
261.01M
89.38%
-14.29M
2023Q4
2815
267.28M
91.36%
-8.83M
2023Q3
2725
267.62M
91.08%
-13.20M
2023Q2
2737
270.13M
91.28%
-8.82M
2023Q1
2710
268.82M
90.70%
-14.56M
2022Q4
2688
273.81M
91.52%
-15.32M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
25.97M
9.49%
+22.81K
+0.08%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.38M
4.89%
+8.79K
+0.06%
Dec 31, 2024
State Street Global Advisors (US)
12.71M
4.64%
-105.72K
-0.82%
Dec 31, 2024
MFS Investment Management
11.22M
4.1%
+489.58K
+4.55%
Dec 31, 2024
T. Rowe Price Associates, Inc.
10.56M
3.86%
-1.11M
-9.58%
Dec 31, 2024
Fidelity Management & Research Company LLC
9.98M
3.64%
-1.67M
-14.37%
Dec 31, 2024
Dodge & Cox
8.77M
3.2%
-16.80K
-0.19%
Dec 31, 2024
Sanders Capital, LLC
8.05M
2.94%
+154.41K
+1.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
5.95M
2.17%
+101.73K
+1.73%
Dec 31, 2024
GQG Partners, LLC
4.02M
1.46%
+737.09K
+22.44%
Dec 31, 2024
查看更多
持股ETF
更新时间: 15 小时前
更新时间: 15 小时前
机构名称
占比
Future Fund Active ETF
12.58%
iShares U.S. Healthcare Providers ETF
9.88%
Monarch Dividend Plus Index ETF
5.07%
Cambria LargeCap Shareholder Yield ETF
4.21%
VictoryShares Free Cash Flow ETF
4.05%
First Trust Large Cap US Equity Select ETF
3.21%
Davis Select US Equity ETF
3.15%
Fidelity Blue Chip Value ETF
2.41%
Hennessy Stance ESG ETF
2.39%
Brandes US Value ETF
2.36%
查看更多
Future Fund Active ETF
占比12.58%
iShares U.S. Healthcare Providers ETF
占比9.88%
Monarch Dividend Plus Index ETF
占比5.07%
Cambria LargeCap Shareholder Yield ETF
占比4.21%
VictoryShares Free Cash Flow ETF
占比4.05%
First Trust Large Cap US Equity Select ETF
占比3.21%
Davis Select US Equity ETF
占比3.15%
Fidelity Blue Chip Value ETF
占比2.41%
Hennessy Stance ESG ETF
占比2.39%
Brandes US Value ETF
占比2.36%
分红派息
近5年累计派现 5.74B 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option
Sep 06, 2023
Sep 21, 2023
Sep 05, 2023
Apr 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option
Jun 07, 2023
Jun 22, 2023
Jun 06, 2023
Feb 03, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option
Mar 08, 2023
Mar 23, 2023
Mar 07, 2023
Oct 26, 2022
CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022
Dec 06, 2022
Dec 21, 2022
Dec 05, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有